Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control (2024)
Attributed to:
The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2024.01.010
Publication URI: http://dx.doi.org/10.1016/j.jcyt.2024.01.010
Type: Journal Article/Review
Parent Publication: Cytotherapy